EP3508856 - NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 30.12.2022 Database last updated on 02.09.2024 | |
Former | Request for examination was made Status updated on 07.06.2019 | ||
Former | The international publication has been made Status updated on 10.03.2018 | Most recent event Tooltip | 27.08.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Lu, Fengmin Peking University Health Science Center 38 Xueyuan Road Beijing 100191 / CN | For all designated states Yao, Mingjie Peking University Health Science Center 38 Xueyuan Road Beijing 100191 / CN | For all designated states Zhao, Jingmin Beijing 302 Hospital 100 Xisihuan Road Beijing 100039 / CN | [2019/28] | Inventor(s) | 01 /
LU, Fengmin Peking University Health Science Center 38 Xueyuan Road Beijing 100191 / CN | 02 /
YAO, Mingjie Peking University Health Science Center 38 Xueyuan Road Beijing 100191 / CN | 03 /
ZHAO, Jingmin Beijing 302 Hospital 100 Xisihuan Road Beijing 100039 / CN | [2019/28] | Representative(s) | Ipsilon Le Centralis 63, avenue du Général Leclerc 92340 Bourg-la-Reine / FR | [N/P] |
Former [2019/28] | Peguet, Wilfried, et al Ipsilon Le Centralis 63, avenue du Général Leclerc 92340 Bourg-la-Reine / FR | Application number, filing date | 17845449.2 | 30.08.2017 | [2019/28] | WO2017CN99714 | Priority number, date | CN201610798291 | 31.08.2016 Original published format: CN201610798291 | [2019/28] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018041147 | Date: | 08.03.2018 | Language: | ZH | [2018/10] | Type: | A1 Application with search report | No.: | EP3508856 | Date: | 10.07.2019 | Language: | EN | [2019/28] | Search report(s) | International search report - published on: | CN | 08.03.2018 | (Supplementary) European search report - dispatched on: | EP | 19.03.2020 | Classification | IPC: | G01N33/68, G01N33/576 | [2020/17] | CPC: |
G01N33/576 (EP);
G01N33/6893 (CN,US);
G01N33/5767 (EP);
G01N33/68 (US);
G01N2800/085 (EP,CN,US);
G01N33/57438 (US)
|
Former IPC [2019/28] | G01N33/68 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/28] | Title | German: | NEUARTIGER LEBERZIRRHOSE- ODER LEBERFIBROSEMARKER | [2019/28] | English: | NOVEL LIVER CIRRHOSIS OR LIVER FIBROSIS MARKER | [2019/28] | French: | NOUVEAU MARQUEUR DE LA CIRRHOSE DU FOIE OU DE LA FIBROSE DU FOIE | [2019/28] | Entry into regional phase | 29.03.2019 | Translation filed | 29.03.2019 | National basic fee paid | 29.03.2019 | Search fee paid | 29.03.2019 | Designation fee(s) paid | 29.03.2019 | Examination fee paid | Examination procedure | 27.06.2018 | Request for preliminary examination filed International Preliminary Examining Authority: CN | 29.03.2019 | Examination requested [2019/28] | 14.10.2020 | Amendment by applicant (claims and/or description) | 04.01.2023 | Despatch of a communication from the examining division (Time limit: M06) | 08.06.2023 | Reply to a communication from the examining division | Fees paid | Renewal fee | 26.08.2019 | Renewal fee patent year 03 | 28.08.2020 | Renewal fee patent year 04 | 30.08.2021 | Renewal fee patent year 05 | 30.08.2022 | Renewal fee patent year 06 | 25.08.2023 | Renewal fee patent year 07 | 27.08.2024 | Renewal fee patent year 08 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO2005026687 (UNIV JEFFERSON [US], et al) [X] 9-11 * whole document, in particular claims 1-22 *; | [A]WO2008060394 (INOVA DIAGNOSTICS INC [US], et al) [A] 1-11* the whole document *; | [X]CN101328214 (GUANGZHOU INST BIOMED & HEALTH [CN]) [X] 9-11 * whole document, in particular claims 1-7 *; | [X]CN101735319 (BEIJING HOTGEN BIOTECH CO LTD) [X] 9-11 * whole document, in particular claims 1-10 *; | [X]CN103604918 (GUANGZHOU INST BIOMED & HEALTH, et al) [X] 9-11 * whole document, in particular claims 1-10 *; | [X]US2014134606 (NEWMAN GALE W [US], et al) [X] 9-11 * whole document, in particular claims 1-20 *; | [XA]CN105189549 (ABBOTT LAB) [X] 9-11 * whole document, in particular par. 26, 29, 101, 111, 182, 241, 269, 272, 297, 310, 329-340 * [A] 1-8; | [X] - QIAO YONG ET AL, "Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection", CLINICAL BIOCHEMISTRY, ELSEVIER INC, US, CA, (20140825), vol. 47, no. 16, doi:10.1016/J.CLINBIOCHEM.2014.08.010, ISSN 0009-9120, pages 216 - 222, XP029091575 [X] 9-11 * whole document, in particular abstract * DOI: http://dx.doi.org/10.1016/j.clinbiochem.2014.08.010 | [X] - TAN Q EN,GUO WEI,ZHANG CHUNYAN, JIONG ET AL, "Value of Golgi protein 73(GP73) for diagnosis and grading of liver cirrhosis", ZHENDUANXUE LILUN YU SHIJIAN -JOURNAL OF DIAGNOSTICS CONCEPTS & PRACTICE, SHANGHAI RUIJIN YIYUAN, CN, (20131231), vol. 12, no. 5, ISSN 1671-2870, pages 516 - 521, XP009513624 [X] 9-11 * whole document, in particular abstract * | International search | [X]WO2005026687 (UNIV JEFFERSON [US], et al) [X] 1-13 * , claims 1-22 *; | [X]CN101328214 (GUANGZHOU INST BIOMED & HEALTH [CN]) [X] 1-13 * , claims 1-7 *; | [X]CN101735319 (BEIJING HOTGEN BIOTECH CO LTD) [X] 1-13 * , claims 1-10 *; | [X]CN103604918 (GUANGZHOU INST BIOMED & HEALTH, et al) [X] 1-13 * , claims 1-10 *; | [X]US2014134606 (NEWMAN GALE W [US], et al) [X] 1-13 * , claims 1-20 *; | [X]CN105189549 (ABBOTT LAB) [X] 1-13 * , description, paragraphs [0026], [0029], [0101], [0111], [0182], [0241], [0269], [0272], [0297], [0310] and [0329]-[0340] *; | [PX]CN106405104 (LU FENGMIN, et al) [PX] 1-13 * , claimsl-13 *; | [PX] - LU , FENGMIN, "Serological diagnosis of hepatocellular carcinoma: challenges and opportunities", Journal of Clinical Hepatology, (20170731), vol. 33, no. 7, doi:10.3969/j.issn.1001-5256.2017.07.011, ISSN 1001-5256, pages 1262 - 1265, XP009513598 [PX] 1-13 DOI: http://dx.doi.org/10.3969/j.issn.1001-5256.2017.07.011 | [X] - QIAO, Y. et al., "Serum gp73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection", Clinical Biochemistry, (20140825), vol. 47, doi:doi:10.1016/j.clinbiochem.2014.08.010, pages 216 - 222, XP029091575 [X] 1-13 DOI: http://dx.doi.org/10.1016/j.clinbiochem.2014.08.010 | [X] - TAN, QIWEN et al., "Value of Golgi protein 73(GP73) for diagnosis and grading of liver cirrhosis", Journal of Diagnostics Concepts & Practice, (20131231), vol. 12, no. 5, ISSN 1671-2870, pages 516 - 521, XP009513624 [X] 1-13 |